These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29632537)

  • 1. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.
    Zou H; Li R; Hu H; Hu Y; Chen X
    Front Immunol; 2018; 9():594. PubMed ID: 29632537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
    Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
    Front Immunol; 2018; 9():583. PubMed ID: 29623079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFR2-expressing CD4
    He J; Li R; Chen Y; Hu Y; Chen X
    Prog Mol Biol Transl Sci; 2019; 164():101-117. PubMed ID: 31383403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
    Leclerc M; Naserian S; Pilon C; Thiolat A; Martin GH; Pouchy C; Dominique C; Belkacemi Y; Charlotte F; Maury S; Salomon BL; Cohen JL
    Blood; 2016 Sep; 128(12):1651-9. PubMed ID: 27506541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
    Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
    Front Immunol; 2018; 9():1274. PubMed ID: 29922294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-TNFR2 Signal Plays a Decisive Role in the Activation of CD4
    Islam MS; Yang Y; Chen X
    Adv Exp Med Biol; 2021; 1278():257-272. PubMed ID: 33523452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.
    Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ
    J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.
    Torrey H; Butterworth J; Mera T; Okubo Y; Wang L; Baum D; Defusco A; Plager S; Warden S; Huang D; Vanamee E; Foster R; Faustman DL
    Sci Signal; 2017 Jan; 10(462):. PubMed ID: 28096513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.
    Salomon BL; Leclerc M; Tosello J; Ronin E; Piaggio E; Cohen JL
    Front Immunol; 2018; 9():444. PubMed ID: 29593717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.
    Zhou Q; Hu Y; Howard OM; Oppenheim JJ; Chen X
    Cytokine; 2014 Jan; 65(1):56-64. PubMed ID: 24080164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted killing of TNFR2-expressing tumor cells and T
    Torrey H; Khodadoust M; Tran L; Baum D; Defusco A; Kim YH; Faustman DL
    Leukemia; 2019 May; 33(5):1206-1218. PubMed ID: 30356161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.
    Yang S; Wang J; Brand DD; Zheng SG
    Front Immunol; 2018; 9():784. PubMed ID: 29725328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.
    Chen X; Wu X; Zhou Q; Howard OM; Netea MG; Oppenheim JJ
    J Immunol; 2013 Feb; 190(3):1076-84. PubMed ID: 23277487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4
    He T; Chen Y; Yang D; Islam MS; Chou CK; Liu J; Faustman DL; Oppenheim JJ; Chen X
    Cell Oncol (Dordr); 2023 Feb; 46(1):167-177. PubMed ID: 36369606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
    Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
    Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4
    He T; Liu S; Chen S; Ye J; Wu X; Bian Z; Chen X
    Front Immunol; 2018; 9():1556. PubMed ID: 30038619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.
    Chen X; Oppenheim JJ
    Curr Dir Autoimmun; 2010; 11():119-34. PubMed ID: 20173391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4
    Chen S; Li R; Chen Y; Chou CK; Zhang Z; Yang Y; Liao P; Wang Q; Chen X
    Biomed Pharmacother; 2022 Jul; 151():113187. PubMed ID: 35676787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and
    Shaikh F; He J; Bhadra P; Chen X; Siu SWI
    Front Immunol; 2018; 9():1382. PubMed ID: 29967617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis.
    Chopra M; Riedel SS; Biehl M; Krieger S; von Krosigk V; Bäuerlein CA; Brede C; Jordan Garrote AL; Kraus S; Schäfer V; Ritz M; Mattenheimer K; Degla A; Mottok A; Einsele H; Wajant H; Beilhack A
    Carcinogenesis; 2013 Jun; 34(6):1296-303. PubMed ID: 23385062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.